142 related articles for article (PubMed ID: 31364167)
1. Immobilization of HIV-1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery.
Ahwazi RP; Kiani M; Dinarvand M; Assali A; Tekie FSM; Dinarvand R; Atyabi F
J Cell Physiol; 2020 Mar; 235(3):2049-2059. PubMed ID: 31364167
[TBL] [Abstract][Full Text] [Related]
2. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
3. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
Kong L; Wu Y; Alves CS; Shi X
Nanomedicine (Lond); 2016 Dec; 11(23):3103-3115. PubMed ID: 27809656
[TBL] [Abstract][Full Text] [Related]
7. Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors.
Panigrahi B; Mishra S; Singh RK; Siddiqui N; Bal R; Mandal D
Int J Pharm; 2019 May; 563():198-207. PubMed ID: 30953762
[TBL] [Abstract][Full Text] [Related]
8. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
Liu B; Cao W; Qiao G; Yao S; Pan S; Wang L; Yue C; Ma L; Liu Y; Cui D
Acta Biomater; 2019 Nov; 99():307-319. PubMed ID: 31513911
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
Kong L; Qiu J; Sun W; Yang J; Shen M; Wang L; Shi X
Biomater Sci; 2017 Jan; 5(2):258-266. PubMed ID: 27921110
[TBL] [Abstract][Full Text] [Related]
10. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
[TBL] [Abstract][Full Text] [Related]
11. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
12. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
13. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
14. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle.
Iranpur Mobarakeh V; Modarressi MH; Rahimi P; Bolhassani A; Arefian E; Atyabi F; Vahabpour R
Int J Biol Macromol; 2019 May; 129():305-315. PubMed ID: 30738164
[TBL] [Abstract][Full Text] [Related]
15. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
[TBL] [Abstract][Full Text] [Related]
16. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of HIV-1 TAT peptide and its conjugated gold nanoparticles translocating across lipid membranes.
Quan X; Sun D; Zhou J
Phys Chem Chem Phys; 2019 May; 21(20):10300-10310. PubMed ID: 31070638
[TBL] [Abstract][Full Text] [Related]
18. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery.
Shirazi AN; Paquin KL; Howlett NG; Mandal D; Parang K
Molecules; 2014 Aug; 19(9):13319-31. PubMed ID: 25170952
[TBL] [Abstract][Full Text] [Related]
19. Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA.
Shaat H; Mostafa A; Moustafa M; Gamal-Eldeen A; Emam A; El-Hussieny E; Elhefnawi M
Int J Pharm; 2016 May; 504(1-2):125-33. PubMed ID: 27036397
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
